Journal article

Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration

Meghan D Morris, Stephen Shiboski, Julie Bruneau, Judith A Hahn, Margaret Hellard, Maria Prins, Andrea L Cox, Gregory Dore, Jason Grebely, Arthur Y Kim, Georg M Lauer, Andrew Lloyd, Thomas Rice, Naglaa Shoukry, Lisa Maher, Kimberly Page

Clinical Infectious Diseases | OXFORD UNIV PRESS INC | Published : 2017

University of Melbourne Researchers

Grants

Awarded by National Institute on Drug Abuse (NIDA)


Awarded by NIH/NIDA


Awarded by NIH National Center for Advancing Translational Sciences


Awarded by Baltimore Before and After Study


Awarded by Transmission, Immunity and Outcomes Network


Awarded by Sydney HITS-c - UNSW Hepatitis C Vaccine Initiative and NHMRC Project


Awarded by Melbourne Networks/MIX National Health and Medical Research Council, Australia (NHMRC) Project


Awarded by Montreal HepCo-the Canadian Institutes of Health Research


Awarded by San Francisco (UFO)


Awarded by Alberta Innovates


Awarded by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES


Awarded by NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM


Awarded by NATIONAL INSTITUTE ON DRUG ABUSE


Funding Acknowledgements

This work was supported by the National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (R01DA599901). M. D. M. is supported by an NIH/NIDA career development award (K01DA037802) and the NIH National Center for Advancing Translational Sciences (KL2TR000143). Research support for the individual cohorts include The Netherlands National Institute for Public Health and the Environment to the Amsterdam Cohort Study; Baltimore Before and After Study (NIH U19 AI088791); BAHSTION Boston Acute HCV Study: Transmission, Immunity and Outcomes Network (NIH U19 AI066345); Sydney HITS-c - UNSW Hepatitis C Vaccine Initiative and NHMRC Project (grant number 630483); Melbourne Networks/MIX National Health and Medical Research Council, Australia (NHMRC) Project (grant numbers 331312 and 545891) and the Victorian Operational Infrastructure Support Programme (Department of Health, Victoria, Australia); Montreal HepCo-the Canadian Institutes of Health Research (MOP-103138 and MOP-106468); San Francisco (UFO) (NIH/NIDA R01 DA016017).